Advances in sleep medicine, explained by the clinic's team.
SFRMS 2026 in Lyon: Sleep Congress, 25-27 November
Lyon, 25-27 November — SFRMS and SPLF
The 2026 Sleep Congress, organised by SFRMS and SPLF, takes place in Lyon from 25 to 27 November: dates, programme, registration. La Clinique du Sommeil will attend.
October 8, 2026
A French version of the Sleep Inertia Questionnaire (SIQ) has been validated to assess sleep inertia, a temporary state of impaired performance after waking. This assessment is particularly relevant for patients suffering from sleep disorders such as obstructive sleep apnea and hypersomnia disorders.
A qualitative study explored clinicians' perspectives on the barriers and facilitators to managing sleep-related breathing disorders in children. The findings highlight the importance of educating parents and access to sleep testing to improve diagnosis and treatment.
October 5, 2026
A recent study analyzed the incidence of narcolepsy in France, as well as its impact on healthcare and associated costs. The results show that individuals with narcolepsy use more healthcare resources and incur higher costs than those without the condition.
A systematic review has shown that sodium oxybate is effective in reducing excessive daytime sleepiness in patients with narcolepsy. The results indicate a significant improvement in sleepiness scores and a reduction in the frequency of cataplexy attacks, with acceptable safety effects.
October 1, 2026
A review of studies shows that rehabilitation interventions, such as physical exercise, can improve the quality of life for individuals suffering from obstructive sleep apnea, even though changes in the apnea-hypopnea index are modest. This underscores the importance of a patient-centered approach.
A new method for detecting obstructive sleep apnea (OSA) using ECG signals has been developed. This approach could improve diagnostic accuracy compared to traditional methods, offering potential for use in home monitoring devices.
September 28, 2026
A systematic review examined the link between insomnia and various health issues, including dementia, depression, and strokes. Insomnia is identified as a predictive factor for these conditions, while its link to mortality is not established. These findings highlight the importance of sleep quality.
September 27, 2026
A study has observed an association between tobacco exposure and obstructive sleep apnea (OSA). Cotinine levels, a metabolite of nicotine, are linked to an increased risk of OSA, whether through active smoking or exposure to secondhand smoke. These findings highlight the importance of reducing tobacco exposure.
September 24, 2026
A study has revealed that individuals suffering from sleep apnea have an increased risk of developing insomnia, particularly among Arab and Black patients. This association does not vary by sex but shows racial and ethnic disparities. These findings underscore the importance of monitoring sleep disorders in these populations.
Restless legs syndrome (RLS) is a common neurological disorder that affects sleep. A recent review highlights the importance of iron, particularly in the brain, in understanding this syndrome. Further research is needed to better target treatments.
September 22, 2026
Researchers have found clues suggesting that long COVID may damage dopamine-releasing neurons in the brain. This could explain symptoms such as persistent fatigue and memory difficulties. This discovery paves the way for new treatments.
September 21, 2026
A recent study examined the burden of insomnia in individuals with major depressive disorder. The results show that insomnia is common and severely affects quality of life, despite the use of treatments. This underscores the importance of addressing both depression and insomnia symptoms.
September 17, 2026
A study examined the relationship between obstructive sleep apnea and circadian rhythm in Brazilian adults. Although associations were observed, they depend on individual characteristics, particularly in women and older individuals. These findings highlight the importance of a personalized approach in managing sleep disorders.
A review of studies examines the effectiveness of cognitive behavioral therapy for insomnia (CBT-I) in reducing or stopping medications like benzodiazepines. The results show uncertainty regarding its effectiveness, but it may assist in personalized tapering programs.
September 13, 2026
A study revealed that the delay in diagnosing narcolepsy, often exceeding one year, is related to the age of onset of symptoms. Younger individuals with earlier symptoms are more likely to experience a delay. Increased awareness is needed to improve diagnosis.
September 12, 2026
A study examined the efficacy and safety of vornorexant, a medication for treating insomnia, over a 52-week period in Japanese patients. The results show an improvement in sleep and good tolerance of the treatment.
September 10, 2026
A recent study reveals that nearly 25% of patients with Parkinson's disease suffer from Restless Legs Syndrome, often undiagnosed. This syndrome is linked to poor sleep quality and an increase in dopaminergic treatments, highlighting the importance of systematic screening.
A recent study highlights the association between obstructive sleep apnea and high blood pressure. While this relationship is recognized, the effectiveness of continuous positive airway pressure treatment in reducing blood pressure remains to be confirmed. Practical tools are emerging to identify at-risk patients.
September 7, 2026
A study examined the link between the endothelial activation and stress index (EASIX) and the severity of obstructive sleep apnea (OSA). The results show that higher levels of EASIX are associated with an increased risk of mortality, both overall and cardiovascular, in individuals suffering from OSA.
Restless Legs Syndrome (RLS) is increasingly recognized as a condition involving dysfunctions of the autonomic nervous system. A systematic review examined how this can affect various aspects of health, including cardiovascular and gastrointestinal, thereby impacting the quality of life of patients.
September 3, 2026
A recent study examines the effect of expiratory pressure relief (EPA) algorithms on the effectiveness of CPAP devices in patients with severe obstructive sleep apnea. The results show that EPA may compromise upper airway patency and require higher CPAP levels.
A systematic review examines the use of audio signals to detect obstructive sleep apnea (OSA). Although polysomnography is the standard, studies show that artificial intelligence could provide an accurate alternative for identifying the risks of moderate to severe OSA.
September 1, 2026
General practitioner Dr Stéphanie Herzog has joined the medical team of the Yutz Sleep Clinic. She handles consultations and patient follow-up, and is currently completing a University Diploma in sleep medicine.
August 31, 2026
A recent study examined the relationship between insomnia and chronic pain. The results show that individuals suffering from insomnia have an increased risk of developing pain, while the reverse is not observed. This underscores the importance of treating insomnia to improve pain management.
A study examined the link between levels of sLRP-1, a protein involved in inflammation and metabolism, and obstructive sleep apnea (OSA) in snoring adults. The results show that lower levels of sLRP-1 are associated with an increased risk of OSA, but further validations are needed before any clinical application.
August 27, 2026
A recent study examined the link between physical activity and insomnia symptoms. The results show that moderate physical activity is associated with a reduced risk of insomnia, while work-related physical activity may increase it. These findings highlight the importance of the nature of physical activity on sleep health.
A study compared the effectiveness of cognitive behavioral therapy for insomnia (CBT-I) and bright light therapy (BLT) in women receiving chemotherapy for breast cancer. The results show that CBT-I improves insomnia symptoms, but not BLT.
August 24, 2026
A recent study examines the association between cannabis use and signs of respiratory disorders during sleep among American adults. The results show a correlation, but causality remains to be established. Further research is needed to better understand this relationship.
A study explored the link between sleep disorders, mild cognitive decline, and frailty in adults with chronic pain. The results show that these disorders are associated with greater frailty, which could influence patient assessments and follow-ups.
